<
Roche invested 880 million US dollars to expand production capacity to create 500 positions
Release time: 2013-10-21 & nbsp & nbsp & nbsp Source: Anonymous

    Roche (Roche) announced on October 14,In the next 5 years,It will invest 800 million Swiss franc (about 880 million US My stake betting appStake Sports Bettingdollars) at its global production base,Create 500 employment opportunities,To meet the growing growth of biological drugs。

    Current,Roche is the world's largest anti -cancer drug producer,The total number of employees in more than 100 countries around the world is about 80,000,The company said on Monday,This investment,It will be used to increase Germany Penzberg、Swiss Basel、The production capacity of Vacaville and Oceanside production facilities。

    This capacity expands,Show Roche's confidence in its anti -cancer new drug research and development pipeline。and in recent weeks,Some large pharmaceutical companies are planning to cut costs,To slow down the growth of sales。Last week,TEVA announced,5,000 people will be layoffs,and Merck & CO) plans to cut annual operating costs 2.5 billion US dollars,At the same time, 10%of employees will be layoffs。

    Swiss Vontobel analyst Andrew Weiss said,I am not surprised by Roche'stake sports betting apps stake sports betting appinvestment,Manufacturing is Roche's core competitiveness,At present, the company is the industry's most & ldquo; thin & rdquo; pharmaceutical company,There are only 15 production bases worldwide。

    Roche's most promising medicine,Many are biological preparations,Ronaldritic arthritis drug Roactemra,Breast cancer new drug Kadcyla and Perjeta,These drugs are different from chemicals,It is difficult to copy。Current,Several competitors are mostly raging in patented cliffs,and Roche are fortunately free,Several best -selling medicines in the company are biological preparations,There is no competition for generic drugs yet。

    Danniel, chief operating officer of the Roche Department of Pharmaceutical Department,As the world's largest biological agent supplier,Roche is committed to making necessary investment,to ensure the highest treatment standard,Continuous supply of these medicines。

    Roche said,It will invest in the production base of Vacaville and Oceanside Stake Sports Bettingin Stake Sports Bettingthe United States about 260 million Swiss franc (about 286 million US dollars),Create about 250 new employment opportunities。At the same time, it will invest in Penzberg, Germany to invest 350 million franc (about 385 million US dollars),Create about 200 jobs。

    In addition,Roche also plans to establish a production facility in Basel, Switzerland,It is used to produce antibody coupling drugs (ADC)。The company's first antibody puppet couplet drug KADCYLA was approved in February this year,This drug is used for the treatment of breast cancer,At the same time, there are fewer side effects。

    Current,Roche has 8 ADC drugs in clinical development,16 ADC drugs are developed in clinical development。